At one year, patients with moderate PAD who were started on GLP-1 RAs had fewer major adverse limb events (MALE) (0.8% vs 1.5%), major adverse cardiac events (MACE) (25.4% vs 29.3%), and decreased risk of hospitalizations (17.9 vs 26.8%)
IGF-1 levels provide an objective measure of HGH activity
Such health benefits prove particularly useful for professionals working at their computers for extended periods of time
Some medications may not be suitable for those with a history of pancreatitis, kidney disease, or thyroid cancer
GLP-1 drugs begin to suppress appetite relatively quickly, often within a few days of starting treatment
If the solution still appears clear and colorless, it may be safe to use, but contact your pharmacist for guidance to ensure the medication hasn't been compromised